Inflammation in dry age-related macular degeneration
- PMID: 17440275
- DOI: 10.1159/000099293
Inflammation in dry age-related macular degeneration
Abstract
Purpose: To summarize the current information regarding the role of immune and inflammatory response in the pathogenesis of dry age-related macular degeneration (ARMD).
Methods: A Pubmed search was conducted of the period January 1999 to 2005. Relevant information in the literature on the role of inflammation in early dry ARMD was reviewed.
Results: Some important evidence for inflammation in early ARMD consists in the isolation of immunoglobulins, complement proteins, cytokines and activated microglia, in retinal pigment epithelium (RPE) cells and drusen. Pivotal mechanisms in early ARMD include the accumulation of debris and proteins along the RPE surface, followed by immune-complex deposition and complement activation. In contrast, the role of other plasma enzymes such as kallikrein-kinin-bradykinin, the Hageman factor, peptides and coagulation proteins in drusen formation and ARMD has yet to be determined.
Conclusion: A clear role for inflammatory mediators and cells has been established in recent years. Future studies should elucidate further mechanisms in ARMD development.
Copyright (c) 2007 S. Karger AG, Basel.
Similar articles
-
Para-inflammation in the aging retina.Prog Retin Eye Res. 2009 Sep;28(5):348-68. doi: 10.1016/j.preteyeres.2009.06.001. Epub 2009 Jun 26. Prog Retin Eye Res. 2009. PMID: 19560552 Review.
-
Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration.J Cell Physiol. 2009 Jul;220(1):119-28. doi: 10.1002/jcp.21742. J Cell Physiol. 2009. PMID: 19277984
-
Complement activation and inflammatory processes in Drusen formation and age related macular degeneration.Exp Eye Res. 2001 Dec;73(6):887-96. doi: 10.1006/exer.2001.1094. Exp Eye Res. 2001. PMID: 11846519
-
Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration.Med Hypotheses. 2009 Apr;72(4):448-50. doi: 10.1016/j.mehy.2008.09.055. Epub 2009 Jan 6. Med Hypotheses. 2009. PMID: 19128888
-
Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.Adv Immunol. 2007;96:141-77. doi: 10.1016/S0065-2776(07)96004-6. Adv Immunol. 2007. PMID: 17981206 Review.
Cited by
-
Elevated neutrophil-to-lymphocyte ratio in pseudoexfoliation syndrome.Eye (Lond). 2016 Aug;30(8):1045-8. doi: 10.1038/eye.2016.89. Epub 2016 May 6. Eye (Lond). 2016. PMID: 27151541 Free PMC article.
-
IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells.Inflammation. 2012 Apr;35(2):776-84. doi: 10.1007/s10753-011-9379-4. Inflammation. 2012. PMID: 21898270
-
Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography.Ophthalmology. 2011 Apr;118(4):687-93. doi: 10.1016/j.ophtha.2010.08.010. Epub 2010 Nov 20. Ophthalmology. 2011. PMID: 21093923 Free PMC article.
-
Age-Related Macular Degeneration in Patients with Androgenetic Alopecia: Could the Monocyte/HDL Ratio Be the Link?Dermatol Pract Concept. 2023 Oct 1;13(4):e2023285. doi: 10.5826/dpc.1304a285. Dermatol Pract Concept. 2023. PMID: 37992380 Free PMC article.
-
Nanotechnology for Age-Related Macular Degeneration.Pharmaceutics. 2021 Nov 29;13(12):2035. doi: 10.3390/pharmaceutics13122035. Pharmaceutics. 2021. PMID: 34959316 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical